Healthcare & Pharmaceuticals
In a move activists hoped would lead to a flood of affordable AIDS medication to Africa, the pharmaceutical industry dropped its suit Thursday challenging a South African law many say would allow the government to import or produce generic versions of the drugs.
LOS ANGELES, Aug. 25 - The attorney general of California sued 39 drug companies on Thursday, accusing them of bilking the state of hundreds of millions of dollars by overcharging for medicines.
Dietary-supplements maker Mannatech Inc. said it settled several lawsuits with shareholders who accused the company of using improper sales tactics to boost the value of the stock.
When individuals sue major corporations, the odds are stacked against them. One woman's fight against an insurance giant details those odds and what it takes to beat them.
Three major pharmaceutical companies - AstraZeneca, Johnson & Johnson and Pfizer - have recently delayed or canceled clinical trials for testing tuberculosis (TB) drugs in India and South Africa. Activists say this is symbolic of a trend by Big Pharma to abandon research into diseases that affect poor people.
The decision by PH Kurian, the controller general of patents, designs and trademarks in India, to allow a local company to manufacture Sorafenib, a drug used to treat advanced kidney cancer and liver cancer, is a welcome move that supports the access of poor people to cheap life-saving drugs.
With billions of dollars in profits on the line, the health care industry is waging the largest national advertising campaign ever conducted by a political special interest, with a price tag for the election cycle that could approach $90 million--more than either of the major presidential candidates is expected to spend.
JOHANNESBURG -- A severe shortage of two antiretrovirals (ARVs) produced by leading pharmaceutical Bristol-Myers Squibb in Kenya, could have critical repercussions for patients, says Medecines sans Frontieres (MSF).
The economic crisis that emerged out the collapse of securities based on shaky U.S. mortgages poses challenges for the Davos World Economic Forum, an arena that has championed market-driven approaches.
Nestle says that it will destroy 400 million packets of Maggi brand instant noodles in India worth some Rs 320 crores ($50.5 million). The company made the announcement after the Food Safety and Standards Authority of India found "hazardous" levels of lead in company products and ordered legal action.